Transition Therapeutics Inc. (TTH.TO) Files Shelf Registration Statement
9/30/2009 9:02:32 AM
More...
|
Transition Therapeutics Inc. (TTH.TO) Announces Fiscal 2009 Year End Financial Results
9/17/2009 8:56:25 AM
More...
|
Transition Therapeutics Inc. (TTH.TO) to Hold Conference Call On Fiscal Year-End 2009 Financial Results On Wednesday, September 16th, At 4:30 P.M. EDT
9/15/2009 12:15:28 PM
More...
|
Transition Therapeutics Inc. (TTH.TO) to Present at Canaccord Adams 29th Annual Global Growth Conference
8/7/2009 10:33:54 AM
More...
|
Elan Corporation PLC (ELN) and Transition Therapeutics Inc. (TTH.TO) Announce Phase 1 Data Showing ELND005 Achieves Desired Concentrations in Brain Tissue and Cerebrospinal Fluid
7/13/2009 9:23:03 AM
More...
|
Transition Therapeutics Inc. (TTH.TO) Announces Appointment of Vice-President of Clinical Operations
6/19/2009 8:32:45 AM
More...
|
Transition Therapeutics Inc. (TTH.TO) Announces Third Quarter Fiscal 2009 Financial Results
5/14/2009 9:39:42 AM
More...
|
Transition Therapeutics Inc. (TTH.TO) to Hold Conference Call on Third Quarter Fiscal 2009 Financial Results on Wednesday, May 13th, at 4:30 P.M. EST
5/12/2009 8:41:16 AM
More...
|
Elan Corporation PLC (ELN) And Transition Therapeutics Inc. (TTH.TO) Receive Key Patent for Alzheimer’s Disease Treatment with ELND005
4/23/2009 9:16:52 AM
More...
|
Transition Therapeutics Inc. (TTH.TO) Announces Initiation of a Phase Ib Clinical Study of TT-223 in combination with a GLP-1 analogue in Patients with Type 2 Diabetes
3/23/2009 8:37:00 AM
More...
|
|